Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chinese Patent Office
Harvard Business School
Express Scripts
Dow
Chubb
McKinsey
Boehringer Ingelheim
Federal Trade Commission

Generated: May 21, 2018

DrugPatentWatch Database Preview

UROVIST CYSTO PEDIATRIC Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Urovist Cysto Pediatric patents expire, and what generic alternatives are available?

Urovist Cysto Pediatric is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in UROVIST CYSTO PEDIATRIC is diatrizoate meglumine. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diatrizoate meglumine profile page.
Summary for UROVIST CYSTO PEDIATRIC
US Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
DailyMed Link:UROVIST CYSTO PEDIATRIC at DailyMed
Drug patent expirations by year for UROVIST CYSTO PEDIATRIC
Medical Subject Heading (MeSH) Categories for UROVIST CYSTO PEDIATRIC

US Patents and Regulatory Information for UROVIST CYSTO PEDIATRIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare UROVIST CYSTO PEDIATRIC diatrizoate meglumine SOLUTION;URETERAL 087731-001 Sep 23, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Fuji
US Department of Justice
Boehringer Ingelheim
Citi
Johnson and Johnson
Merck
UBS
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.